CLGN - CollPlant Biotechnologies Ltd.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
-0.04 (-0.53%)
At close: 03:53PM EDT
Stock chart is not supported by your current browser
Previous close7.48
Bid7.44 x 1000
Ask8.49 x 900
Day's range7.26 - 7.60
52-week range4.27 - 13.97
Avg. volume7,555
Market cap84.704M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs

    EDEN PRAIRIE, Minn. & REHOVOT, Israel, April 04, 2023--Stratasys Ltd. (Nasdaq: SSYS) and CollPlant Biotechnologies (Nasdaq: CLGN) today announced a joint development and commercialization agreement to collaborate on the development of a solution to bio-fabricate human tissues and organs using Stratasys’ P3 technology-based bioprinter and CollPlant’s rh-Collagen-based bioinks. The first project focuses on the development of an industrial-scale solution for CollPlant's regenerative breast implants